Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

INS.L (INS)

There is currently no data for INS.L

Recent Trades History INS.L (INS)

Buy/Sell Volume Trade Prc Trade Type Trade Time

Share Price History for INS.L

Time period:
to
Date Open High Low Close Volume

Share News for INS.L

TRADING UPDATES: Instem acquisition by Ichor sanctioned by UK court

16th Nov 2023 19:30

(Alliance News) - (Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

TRADING UPDATES: Actual Experience appoints administrators

7th Nov 2023 18:11

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

IN BRIEF: Instem shareholders back motions relating to Archimed offer

3rd Nov 2023 20:45

Instem PLC - Staffordshire, England-based provider of IT services to life sciences market - On Thursday, reports required majority of shareholders back the resolution to approve the scheme by which the takeover of Instem by Archimed SAS will be facilitated. Further, shareholders approve special resolution to amend company's articles. Plans to seek court sanction of the scheme on November 16, with the scheme becoming effective on November 20. Read More

UK shareholder meetings calendar - next 7 days

26th Oct 2023 15:47

Read More

IN BRIEF: Instem adjourns meeting after disclosing further approaches

18th Oct 2023 16:57

Instem PLC - Staffordshire, England-based provider of IT services to life sciences market - Intends to adjourn the court meeting and the general meeting relating to the Archimed offer. These were scheduled to be held on October 19 and will now take place on November 2. Decision follows the disclosure by Instem today that since August 30, when the Archimed bid was announced, the firm has received approaches from five separate parties which could have led to a competing offer. However, states all parties have now withdrawn their interest. Believes shareholders should be allowed extra time to consider their votes, hence the delay. Stresses the Archimed offer will not lapse as a result of this announcement. Reaffirms view that the Archimed offer ascribes a highly attractive valuation. Read More

FTSE 100 Latest
Value7,952.62
Change20.64

Login to your account

Forgot Password?

Not Registered